When I evaluate a sweetener for a patient, I run it through five questions rather than one: Does it raise blood sugar and insulin
Carmot is developing CT-388, a GLP-1/GIP receptor agonist
Abbreviations AMPK: AMP-activated protein kinase DPP-4: Dipeptidyl peptidase-4 GIP: Glucose-dependent insulinotropic polypeptide GLP-1: Glucagon-like peptide 1 PPAR: Peroxisome proliferator-activated receptor References Nathan DM, Buse JB, Davidson MB et al (2009) Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
As a result, the researchers say there is not yet enough evidence to conclude that the drugs are more effective specifically for treating binge eating disorder
Preserves Lean Muscle Mass: When you're dieting to lose weight, your body might burn muscle along with fat
While no drug is yet approved specifically for slowing aging, GLP-1s are redefining whats possible by improving multiple age-related conditions